Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Zura Bio Limited - Class A Ordinary shares (NQ:ZURA)

6.770 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	932
Open	6.770
Bid (Size)	6.590 (100)
Ask (Size)	7.000 (600)
Prev. Close	6.770
Today's Range	6.770 - 6.770
52wk Range	0.9700 - 7.190
Shares Outstanding	62,064,270
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Today 6:30 EST

From Zura Bio Limited

Via Business Wire

Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million ↗

February 25, 2026

This biotech specializes in monoclonal antibody therapies for inflammatory and immunological diseases with significant unmet needs.

Via The Motley Fool

Performance

YTD	+22.0%	+22.0%
1 Month	+5.3%	+5.3%
3 Month	+76.3%	+76.3%
6 Month	+219.3%	+219.3%
1 Year	+446.0%	+446.0%

More News

This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges ↗

February 25, 2026

Via The Motley Fool

Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst ↗

February 25, 2026

Via The Motley Fool

Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

February 25, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

February 24, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors

February 23, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit

February 04, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer

January 21, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Reports Business Updates and Outlook for 2026

January 12, 2026

From Zura Bio Limited

Via Business Wire

Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates

November 13, 2025

From Zura Bio Limited

Via Business Wire

Unusual volume stocks are being observed in Wednesday's session. ↗

October 01, 2025

Via Chartmill

Here are the top movers in Tuesday's session. ↗

September 30, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 30, 2025

Via Benzinga

These stocks are moving in today's session ↗

September 30, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 29, 2025

Via Benzinga

Top stock movements in today's session. ↗

September 29, 2025

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

September 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 29, 2025

Via Benzinga

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2025

Via Benzinga

Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

August 20, 2025

From Zura Bio Limited

Via Business Wire

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

August 14, 2025

From Zura Bio Limited

Via Business Wire

Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well ↗

August 11, 2025

Via Stocktwits

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 17, 2025

From Zura Bio

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 17, 2025

Via Benzinga

Frequently Asked Questions

Is Zura Bio Limited - Class A Ordinary shares publicly traded?

Yes, Zura Bio Limited - Class A Ordinary shares is publicly traded.

What exchange does Zura Bio Limited - Class A Ordinary shares trade on?

Zura Bio Limited - Class A Ordinary shares trades on the Nasdaq Stock Market

What is the ticker symbol for Zura Bio Limited - Class A Ordinary shares?

The ticker symbol for Zura Bio Limited - Class A Ordinary shares is ZURA on the Nasdaq Stock Market

What is the current price of Zura Bio Limited - Class A Ordinary shares?

The current price of Zura Bio Limited - Class A Ordinary shares is 6.770

When was Zura Bio Limited - Class A Ordinary shares last traded?

The last trade of Zura Bio Limited - Class A Ordinary shares was at 02/26/26 04:00 PM ET

What is the market capitalization of Zura Bio Limited - Class A Ordinary shares?

The market capitalization of Zura Bio Limited - Class A Ordinary shares is 420.18M

How many shares of Zura Bio Limited - Class A Ordinary shares are outstanding?

Zura Bio Limited - Class A Ordinary shares has 420M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.